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Sirs: Cervical dystonia is very rare
in patients with multiple sclerosis.
A case is reported in which cervical
dystonia was the initial manifesta-
tion of multiple sclerosis. Although
a simple coincidence of multiple
sclerosis and cervical dystonia can-
not be excluded, epidemiological
data and pathophysiological con-
siderations make a causal correla-
tion more likely. Multiple sclerosis
as the cause of secondary cervical
dystonia may probably be under-
recognized.
Typical signs and symptoms of
the first manifestation of multiple
sclerosis (MS) include sensory
disturbances, motor paresis, optic
neuritis, and eye motility disorders
[5]. Sustained dystonia, unlike
paroxysmal movement disorders
[1], is considered an extremely rare
manifestation of MS [6, 9, 10, 13,
15]. We describe a patient in whom
cervical dystonia was the present-
ing feature of MS.
A 38-year old woman of Italian
origin presented with a ten month
history of cervical dystonia with
combined leftward rotation of 70
degrees and rightward tilt of 40
degrees, partially relieved by
touching the left cheek, but persist-
ing during sleep. Transitory im-
provement had been achieved with
tiapride and biperiden. Three days
before admission she noted loss of
right retroauricular sensation. On
admission, she was taking biperi-
den 12 mg/d, tizanidine 6 mg/d, and
clonazepam 1.5 mg/d for the dysto-
nia, as well as citalopram 20 mg/d
for panic attacks. She had no his-
tory of exposure to neuroleptic
drugs prior to onset of dystonia,
drug or alcohol addiction, perinatal
asphyxia, trauma, arterial hyper-
tension or diabetes. Her family his-
tory did not reveal any patients
with movement disorders or psy-
chiatric diseases.
Neurological examination
showed 12 points on the Tsui rating
scale [14] for cervical dystonia, and
hypesthesia behind and below the
right ear, most likely corresponding
to segments C2 and C3, but no
other pathological signs. Slit-lamp
examination excluded Kayser-
Fleischer rings. Blood tests showed
normal results for cell counts,
electrolytes, liver and renal func-
tion, thyroid stimulating hormone,
vitamin B 12, and ceruloplasmin.
Enzyme-immuno-assays for herpes
simplex virus, tick borne ence-
phalitis, treponema, and borrelia
were negative. Cell count (3.0 x 109
(reference < 4.8 x 109)) and total
protein content (354 mg/l (refer-
ence < 480 mg/l)) of the cere-
brospinal fluid were normal, but
intrathecal IgG production was
shown by the presence of four
oligoclonal bands and an elevated
IgG Index (13.6, reference < 7.0).
MRI of the cervical spine showed
two non-enhancing lesions right
dorso-laterally at levels C3/4 and
C2/3 (Fig. 1A). Cranial MRI re-
vealed two right-hemispheric ovoid
lesions in periventricular (Fig. 1B
and C) and juxtacortical areas
(Fig. 1D). Visual evoked potentials
of both eyes were within normal
limits, but the side difference was
abnormal (Fig. 2A). Somato-sen-
sory evoked potentials recorded
after stimulation of the left arm
showed a markedly reduced ampli-
tude of the potentials recorded
from the scalp (Figs. 2B and C).
A diagnosis of laboratory sup-
ported definite MS (according to
Poser’s criteria) or of MS (accord-
ing to the new diagnostic criteria
by McDonald et al. [8], i. e., two
attacks, clinical evidence of one
lesion, three MRI-detected lesions
consistent with MS plus positive
CSF) was made. The patient im-
proved after injection of botulinum
toxin A into the neck muscles com-
bined with pulsed high-dose intra-
venous methylprednisolone
(500 mg daily for five days). She
received the last injection of botu-
linum toxin 12 months after the
first presentation. Fifteen and 27
months after the first presentation,
she showed only minimal signs of
cervical dystonia (both times 3
points on the Tsui scale). Her med-
ication at the last consultation con-
sisted of tizanidine 6 mg/d, alpra-
zolam 1 mg/d, paroxetine 40 mg/d,
and mianserine 30 mg/d. Except for
tizanidine, the other medications
were for psychiatric symptoms.
In most cases of focal dystonia,
the cause remains unknown, lead-
ing to a diagnosis of primary
dystonia. In contrast, some clinical
“red flags” were present in our case
and pointed to secondary focal
dystonia. Sensory deficits in the C2
and C3 dermatomes and persis-
tence of dystonia during sleep were
suggestive of secondary focal
dystonia. Paraclinical examinations
such as imaging, electrophysiologi-
cal and laboratory testing sup-
ported the diagnosis of MS.
We cannot exclude a coinci-
dence of MS and focal dystonia in
our case. However, the probability
of such a coincidence is extremely
low (1: 3.500.000) according to re-
ported prevalences of MS in Italy of
50/100.000 [12], and of cervical
dystonia of 57/100.000 [3]. Further-
more, the persistence of cervical
dystonia, also during sleep, is a
strong argument for secondary,
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Fig. 1 A: MRI of the cervical spine: T2-weighted ax-
ial section at level C3/C4. Hyperintense lesion is pre-
sent right dorso-laterally. B–D: MRI of the head.
FLAIR sequences. Right-hemispheric ovoid lesions in
periventricular (B, C) and juxtacortical location (D).
Note rightward head tilt due to dystonia. The lesions
did not enhance with gadolinium in T1-weighted im-
ages
Fig. 2 A: Visual evoked potentials. The latency of
component P100 on both sides (right: 99.0 ms; left:
108.0 ms) is within the range of normal values, but
the side difference (9.0 ms, normal < 6.0 ms) is
pathological, with prolongation of recording after
stimulation of the left eye. The upper two traces: av-
eraged curves of 200 recordings each. Lower traces:
average of the two curves. L denotes recording after
stimulation of the left eye; R, after stimulation of the
right eye. B and C: Somato-sensory evoked poten-
tials: Recordings after stimulation of the right median
nerve at the wrist (B); of the left median nerve at the
wrist (C). The top traces represent the recordings
from the scalp, the bottom traces, from the processus
spinosus C6. The reference was at Fz. Latencies of P15
and N20 are within normal limits, without patholog-
ical side differences. Components N9, N11, and N13
after stimulation of the left arm can not be identified
(probably for technical reasons in the presence of
dystonia); the potentials recorded from the scalp
show a markedly reduced amplitude (diminution of
amplitude N20-P25 by 86 %; normal < 45 %)
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i. e., in this case MS-related, dysto-
nia [11]. Thus, we propose the
alteration of central processing
produced by an MS lesion as the
more likely explanation for the
cervical dystonia in the present
case [7]. Anecdotal reports de-
scribe torticollis resulting from
different cervical lesions [2, 4] and
the association of spinal MS
plaques with torticollis [6] and
hand dystonia [15]. However, dys-
tonia was not the first manifesta-
tion of MS in any of these reports.
To conclude, MS may probably
be an underdiagnosed cause of
secondary focal dystonia, and con-
versely, secondary focal dystonia
may herald multiple sclerosis and
should be included in the differen-
tial diagnosis of patients present-
ing with this clinical feature.
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